Academic Journal

Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome

التفاصيل البيبلوغرافية
العنوان: Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome
المؤلفون: Grace H. Attrill, Hansol Lee, Annie T. Tasker, Nurudeen A. Adegoke, Angela L. Ferguson, Ines Pires da Silva, Robyn P. M. Saw, John F. Thompson, Umaimainthan Palendira, Georgina V. Long, Peter M. Ferguson, Richard A. Scolyer, James S. Wilmott
المصدر: Frontiers in Immunology, Vol 13 (2022)
بيانات النشر: Frontiers Media S.A., 2022.
سنة النشر: 2022
المجموعة: LCC:Immunologic diseases. Allergy
مصطلحات موضوعية: primary melanoma, immunophenotyping, spatial pathology, T cell phenotypes, Clinicopathological features, Immunologic diseases. Allergy, RC581-607
الوصف: While the tumor immune microenvironment (TIME) of metastatic melanoma has been well characterized, the primary melanoma TIME is comparatively poorly understood. Additionally, although the association of tumor-infiltrating lymphocytes with primary melanoma patient outcome has been known for decades, it is not considered in the current AJCC melanoma staging system. Detailed immune phenotyping of advanced melanoma has revealed multiple immune biomarkers, including the presence of CD8+ T-cells, for predicting response to immunotherapies. However, in primary melanomas, immune biomarkers are lacking and CD8+ T-cells have yet to be extensively characterized. As recent studies combining immune features and clinicopathologic characteristics have created more accurate predictive models, this study sought to characterize the TIME of primary melanomas and identify predictors of patient outcome. We first phenotyped CD8+ T cells in fresh stage II primary melanomas using flow cytometry (n = 6), identifying a CD39+ tumor-resident CD8+ T-cell subset enriched for PD-1 expression. We then performed Opal multiplex immunohistochemistry and quantitative pathology-based immune profiling of CD8+ T-cell subsets, along with B cells, NK cells, Langerhans cells and Class I MHC expression in stage II primary melanoma specimens from patients with long-term follow-up (n = 66), comparing patients based on their recurrence status at 5 years after primary diagnosis. A CD39+CD103+PD-1- CD8+ T-cell population (P2) comprised a significantly higher proportion of intratumoral and stromal CD8+ T-cells in patients with recurrence-free survival (RFS) ≥5 years vs those with RFS
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1664-3224
Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2022.979993/full; https://doaj.org/toc/1664-3224
DOI: 10.3389/fimmu.2022.979993
URL الوصول: https://doaj.org/article/a796eeddfd624bc8b912dd7adc427415
رقم الانضمام: edsdoj.796eeddfd624bc8b912dd7adc427415
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:16643224
DOI:10.3389/fimmu.2022.979993